Search Media Items

Cancer drug discovery and development has long been a priority for the National Cancer Institute, most importantly in areas of need that are not being adequately addressed by the private sector.

The prevention of cancer and the development of more effective strategies to detect cancer precursors and early stage cancers, when treatment may be most effective, remain critical goals.

Resumen de información revisada por expertos sobre el uso de la nutrición y los suplementos alimentarios para disminuir el riesgo de presentar cáncer de próstata o como tratamiento del mismo.

Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer.

Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer.

Dr. Jonathan S. Wiest obtained a bachelor’s degree in analytical chemistry from the University of Wisconsin-Milwaukee in 1980.

NCI convened a workshop of representative research teams that have been leaders in defining the genomic landscape of childhood cancers to discuss the influence of genomic discoveries on the future of childhood cancer research.

Información sobre el estudio del NCI: Análisis Molecular para Selección de Tratamientos (NCI-MATCH), en el cual los investigadores examinarán tejidos de tumor de pacientes con tumores sólidos y linfomas avanzados que han dejado de responder al tratamiento.

Adding aprepitant to the anti-nausea drug ondansetron, with or without dexamethasone, effectively prevents chemotherapy-induced nausea and vomiting in children.

In this precision medicine clinical trial, children and adolescents with advanced cancers whose tumors have certain genetic mutations will be treated with drugs that are matched to those mutations.